Navidea Biopharmaceuticals, Inc.

Subchapter V · Sale Process

Case No. 25-11779·Delaware·Petition date Oct 1, 2025

Research this case Track this case Sign in

OverviewHearings Professionals

Cases

CourtFilingsPetition dateMore filters

Case

Funded debt

Stage

Exit

Next hearing

Last activity

Petition date

Court

Navidea Biopharmaceuticals, Inc.

Subchapter V · Sale Process

Case No. 25-11779·Delaware·Petition date Oct 1, 2025

Research this case Track this case Sign in

OverviewHearings Professionals

Professionals

Retained professionals and compensation participants, joined to their source filings.

Bielli & Klauder, LLC

Fee applicant

Epiq Corporate Restructuring, LLC

Retained · fee applicantAdministrative Advisor · Claims and Noticing Agent · Debtor

Dkt. 110
Dkt. 8
Dkt. 21

Pashman Stein Walder Hayden P.C.

Retained · fee applicantBankruptcy Counsel · Debtor

Dkt. 37

Pashman Stein Walder Hayden, P.C. as Counsel for the Debtor and Debtor in Possession

Fee applicant

SSG Advisors, LLC

RetainedInvestment Banker · Debtor

Dkt. 147
Dkt. 163

Judge: J. Kate Stickles
Petition assets: $1M–$10M
Petition liabilities: $1M–$10M
Industry: Biotechnology, Pharmaceuticals

Develops immunodiagnostic agents and immunotherapeutics. Previously commercialized Lymphoseek (sold to Cardinal Health in 2017), now focusing on developing an Improved API for generic and therapeutic applications

Next hearing

Aug 20, 2026

2:30 PM ET

Claims & Administration · Scheduled

Case background, summaries, and key terms are generated from the filings on this docket. Docket entries and documents come from the court.

Report a data error